申请人:Guo Xialing
公开号:US08614234B2
公开(公告)日:2013-12-24
The present invention is directed to novel compounds of Formula I. The compounds of the present invention are potent tyrosine kinase modulators, and are suitable for the treatment and prevention of diseases and conditions related to abnormal activities of tyrosine kinase receptors.
本发明涉及一种新的I式化合物。本发明的化合物是有效的酪氨酸激酶调节剂,并适用于治疗和预防与酪氨酸激酶受体异常活动相关的疾病和情况。